Trade COAG stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Hemab Therapeutics Holdings, Inc. (COAG) is trading at US$38.25, up 0.74% today as of Sep 22, 16:00 EDT. The company has a market capitalisation of US$2.3B. Over the past 52 weeks, COAG has traded between US$23.00 and US$55.42. On Syfe you can trade COAG with $0 commission and add it to your watchlist.
| Previous close | US$37.97 |
|---|---|
| Market cap | US$2.3B |
| 52-week range | US$23.00 – US$55.42 |
| Volume | 549.12K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Hemab Therapeutics Holdings, Inc.
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company. It engages in developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. The company was founded in 2020 and is headquartered in Cambridge, MA.
Year: 2026
Wedbush Adjusts Price Target on Hemab Therapeutics to $64 From $55, Keeps Outperform Rating
Aug 11, 3:48 PM · MT Newswires
Hemab Therapeutics' Q2 Net Loss Narrows
Aug 11, 11:33 AM · MT Newswires
--Earnings Flash (COAG) Hemab Therapeutics Posts Q2 Net Loss $0.80 a Share, vs. FactSet Est of $0.56 Loss
Aug 11, 11:16 AM · MT Newswires
Hemab Therapeutics' Sutacimig Continues to Support Durable Bleed Reduction, Wedbush Says
Jul 14, 2:50 PM · MT Newswires
Hemab Therapeutics Holdings, Inc. (COAG) stock is trading at US$38.25, +0.74% from the previous close of US$37.97.
The market cap for Hemab Therapeutics Holdings, Inc. (COAG) stock is approximately US$2.3B.
The 52-week high for Hemab Therapeutics Holdings, Inc. (COAG) stock is US$55.42.
The 52-week low for Hemab Therapeutics Holdings, Inc. (COAG) stock is US$23.00.
Hemab Therapeutics Holdings, Inc. (COAG) does not currently pay a dividend.
Stay on top of COAG
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
